Asia
Event held in coordination with World Health Organization regional office
The Ministry of Health and Prevention (MOHAP) has announced the second phase completion of its initiative, ‘Heart Experts,’ which designates a select group of students to serve as awareness ambassadors for cardiovascular health in their schools, neighborhood and local community.
Dubai South has signed a Memorandum of Understanding (MOU) with the UAE Ministry of Health and Prevention (MOHAP) as part of its efforts to strengthen cooperation with the pharmaceutical sector and enable pharmaceutical companies to take advantage of the opportunities to operate within Dubai South.
Cambridge, Mass.-based Biogen exercised its option to acquire additional shares of South Korea’s Samsung Bioepis. Samsung Bioepis focuses on developing biosimilar drugs and is a joint venture between Samsung Biologics and Biogen formed in 2012.
At the 11th Clinical Trials in Alzheimer’s Disease Conference
An above-average rise at 4% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study.
Janssen agreed to pay Yuhan $50 million in upfront money. Yuhan said that Janssen will be responsible for the development of lazertinib. Janssen will also be responsible for manufacturing and commercialization of the drug.
On a Structurally Novel Class of Sting Agonist at 33rd Sitc Annual Meeting
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
BeiGene, Ltd. today announced the acceptance by the China National Medical Products Administration (NMPA) of a new drug application (NDA) for zanubrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor
PRESS RELEASES